In vivo optical imaging of vascular changes and vascular leak is an emerging modality for studying altered physiology in a variety of different cancers and inflammatory states. In oncology, increases in tumor vascular permeability can be an early indicator of tumor angiogenesis. In inflammatory disease increased vascular permeability can indicate alterations in fluid homeostasis in an acute edema response or in chronic organ conditions.
爱游戏平台注册登录 ’s IVISense™ Vascular NIR fluorescent probes (AngioSense®) are designed to evaluate vascular changes to better understand various disease states or provide valuable information on the effects of drug candidates earlier in the development process.
For research use only. Not for use in diagnostic procedures.
false false
IVISense Vascular 750 fluorescent imaging probe (AngioSense 750EX) is an in vivo blood pool vascular agent that remains localized in the vasculature for extended periods of time (0-4 hrs) enabling imaging of vascularity, perfusion, and vascular permeability at a wavelength of 750 nm. The probe accumulates in tumors and arthritic joints at 24 hrs. IVISense Vascular 750 can be used as a single probe or multiplexed with probes at other wavelengths.
| 熒光劑類型 | Vascular |
|---|---|
| 光學成像分類 | Fluorescence Imaging |
| 產品品牌名稱 | IVISense |
| 包裝量 | 1.0 Units |
| 運輸條件 | 藍冰 |
| 治療領域 | Vascular disease, Angiogenesis, Arthritis, Inflammation, Oncology/Cancer |
| 產品尺寸 | 1 Vial (10 doses) |
| 波長 | 750 nm |
Researchers trust our in vivo imaging solutions to give them reliable, calibrated data that reveals pathway characterization and therapeutic efficacies for a broad range of indications. Our reagents, instruments, and applications support have helped hundreds of research projects over the years. And ...
Our comprehensive range of bioluminescent and fluorescent imaging reagents provide researchers with the necessary tools to better understand early disease-related biological changes, track disease progression, help guide the drug discovery process, and evaluate efficacy and safety of drug candida ...
Fluorescence molecular imaging is the visualization of cellular and biological function in vivo to gain deeper insights into disease processes and treatment effects. Designing an effective study from the beginning can help save time and resources.
Learn about several important best p ...
Optical-based in vivo imaging of vascular changes and vascular leak is an emerging modality for studying altered physiology in a variety of different cancers and inflammatory states. A number of fluorescent imaging probes that circulate with the blood, but have no target selectivity, have been used ...
AngioSense™ 750 EX (NEV10011EX) imaging protocol for preparing mice, AngioSense 750EX agent, injection of agent into mice and imaging of mice in IVIS and FMT imaging systems
The goal of in vivo fluorescence molecular imaging is to enable non-invasive visualization and quantification of cellular and biological functioning to better understand and characterize disease processes and treatment effects earlier within the context of a biological system.
This s ...
A novel NIR dye for in vivo temporal tracking of labeled macrophages to sites of acute inflammation
The primary goal of preclinical imaging is to improve the odds of clinical success and reduce drug discovery and development time and costs. Advances in non-invasive in vivo imaging techniques have raised the use of animal models in drug discovery and development to a new level by enabling quick ...
